Skip to main content

APO DA 20 Pill - white round

Pill with imprint APO DA 20 is White, Round and has been identified as Dasatinib 20 mg. It is supplied by Apotex Corp.

Dasatinib is used in the treatment of Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Dasatinib 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO DA 20

Dasatinib

Imprint
APO DA 20
Strength
20 mg
Color
White (white to off-white)
Shape
Round (biconvex film-coated)
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
Manufacturer
Apotex Inc.
National Drug Code (NDC)
60505-3628

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.